Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study.
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort.
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis.
Lenalidomide use in myelodysplastic syndromes: Insights into the biologic mechanisms and clinical applications.
Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents.
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets.